calpain inhibitor 2 has been researched along with s 8932 in 1 studies
| Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (s 8932) | Trials (s 8932) | Recent Studies (post-2010) (s 8932) |
|---|---|---|---|---|---|
| 68 | 0 | 13 | 1,246 | 52 | 1,207 |
| Protein | Taxonomy | calpain inhibitor 2 (IC50) | s 8932 (IC50) |
|---|---|---|---|
| NS5 | Zika virus | 1.36 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.525 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Hurst, B; Ma, C; Szeto, T; Tarbet, B; Wang, J | 1 |
1 other study(ies) available for calpain inhibitor 2 and s 8932
| Article | Year |
|---|---|
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Caco-2 Cells; Carbonates; Cathepsin L; Cell Line; Chlorocebus aethiops; Coronavirus 229E, Human; Coronavirus 3C Proteases; Coronavirus NL63, Human; Coronavirus OC43, Human; COVID-19 Drug Treatment; Drug Combinations; Glycoproteins; HEK293 Cells; Humans; Leucine; Middle East Respiratory Syndrome Coronavirus; Oligopeptides; Proline; SARS-CoV-2; Serine Endopeptidases; Sulfonic Acids; Vero Cells | 2021 |